Better Buy: Gilead Sciences vs. Amgen

Times are certainly changing for Gilead Sciences (NASDAQ: GILD) and Amgen (NASDAQ: AMGN).

Both of these big biotechs are shifting their therapeutic focuses. Both hope to change their future prospects for the better in the process. Which of these biotech stocks is more likely to be the bigger winner for investors? Here's how Gilead and Amgen stack up against each other.

Image source: Getty Images.

Continue reading

Source Fool.com